Sudarshan Pharma Industries Ltd Financial Ratios
SUDARSHAN · Commodities · Current price ₹35
P/E ratio
36.1x
P/B ratio
5.7x
ROE
15.0%
ROCE
12.8%
Debt / Equity
1.84
Dividend yield
0.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 36.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 15.0% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 12.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.84 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Sudarshan Pharma Industries Ltd's latest numbers.
Sudarshan Pharma Industries Ltd profitability
Sudarshan Pharma Industries Ltd generates a return on equity of 15.0% and a return on capital employed of 12.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.84 and a P/E of 36.1x, Sudarshan Pharma Industries Ltd is carrying meaningful debt. Our overall business-quality score for the company is 4.4 / 10.
Understand the ratios
More on Sudarshan Pharma Industries Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.